Sulforaphane

Known Side Effects

Evidence is limited regarding comprehensive safety data for sulforaphane. While several clinical trials have been completed (including studies in autism spectrum disorder, prostate cancer, and breast cancer), detailed safety profiles from these studies are not available in the provided evidence.

Based on the available clinical trial data, sulforaphane has been studied in various populations including:

• Children with autism spectrum disorder (Phase 1/2 trial)
• Patients with recurrent prostate cancer (Phase 2 trial)
• Patients with metastatic breast cancer (Phase 2 trial)
• Healthy adult males (Phase 1 trial)

The completion of these trials suggests sulforaphane was generally tolerated, but specific adverse event data is not provided in the evidence.

Contraindications and Populations to Avoid

No specific contraindications are established in the provided evidence. The research focuses primarily on therapeutic mechanisms rather than safety restrictions.

Evidence is particularly thin regarding:

• Use during pregnancy and breastfeeding
• Pediatric dosing safety (despite one autism study in children)
• Use in patients with severe liver or kidney disease
• Long-term safety data

Drug Interactions

No drug interactions are documented in the provided evidence. This represents a significant knowledge gap, as sulforaphane may theoretically interact with medications metabolized through pathways it influences (such as Nrf2-regulated enzymes).

Special Considerations

Given that sulforaphane is naturally found in cruciferous vegetables like broccoli, it has a history of dietary consumption. However, therapeutic doses used in clinical trials may differ significantly from dietary intake levels.

The preclinical research suggests sulforaphane has multiple biological targets, including mitochondrial function and cellular antioxidant pathways, which could theoretically interact with various medications or medical conditions.

Evidence Limitations

The safety evidence is notably incomplete. While multiple clinical trials have been conducted, the provided evidence lacks:

• Detailed adverse event reporting
• Drug interaction studies
• Long-term safety follow-up data
• Dosing safety parameters
• Population-specific safety considerations

Medical Disclaimer: This information is for educational purposes only and should not replace professional medical advice. Consult with a healthcare provider before using sulforaphane therapeutically, especially if you have medical conditions or take medications.